AN2 Therapeutics Inc

NASDAQ ANTX

Data sourced from iex and EODHD
Download Data

AN2 Therapeutics Inc Income Statement 2021 - 2024

This table shows the Income Statement for AN2 Therapeutics Inc going from 2021 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - 0 - 0 0 0 - - - - - - -
Gross Profit
M - 0 - 0 0 0 - - - - - - -
Operating Expenses
M - 19 - 17 16 12 - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 4 4 4 3 4 4 3 4 2 2 2 1 0
Research and Development (R&D) Expenses
M 15 15 14 14 12 9 8 7 6 6 5 4 2
Other Operating Expenses
M - 0 - 0 0 0 - - - - - - -
Costs and Expenses
M - 19 - 17 16 12 - - - - - - -
Operating Income
M -18 -19 -18 -17 -16 -12 -12 -10 -8 -8 -7 -5 -2
Interest Expense
M - 1 - - -1 1 0 0 0 - 0 0 0
Non-operating Income/Expense
M 2 2 1 1 1 1 0 0 0 0 0 0 0
EBT
M -17 -17 -17 -16 -15 -12 -11 -10 -8 -8 -7 -5 -2
Income Tax Provision
M -18 0 0 0 -1 1 0 0 0 - - - -
Income after Tax
M 2 -17 -17 -16 -15 -13 -11 -10 -8 - - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 2 - 2 2 1
Net Income
M - - - -16 -15 -12 -11 -10 -9 - -9 -7 -3
Shares (Basic, Weighted)
M - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 29,763,278.00 29,735,397.00 25,645,421.00 19,497,494.00 19,385,646.00 19,352,854.00 19,347,148.00 19,258,066.00 3,180,717.00 18,139,786.00 14,047,684.00 14,047,684.00 14,047,684.00
EBITDA
M -18 -19 -18 -17 -16 -12 -12 -10 -8 -8 -7 -5 -2
Depreciation and Amortization
M 18 0 0 0 0 -1 0 0 0 - - - -
EBIT
M -37 -19 -18 -17 -16 -12 -12 -10 -8 - -7 -5 -2
Income from Discontinued Operations
M - - - - - - - - - - - - -
Tax Rate (Effective)
% 110.10 0.11 0.11 0.13 4.67 -7.98 3.80 4.36 0.72 - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% - 50.00 - - - - - - - - - - -
Operating Income Margin
% - -23,518.75 - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - -
EBITDA Ratio
% - -23,518.75 - - - - - - - - - - -
EBIT Ratio
% - -23,542.27 - - - - - - - - - - -
EBT Ratio
% - -21,122.50 - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email